2024 POC/Decentralized Lipid Testing Market: Country Supplier Shares, Test Volume and Sales Segment Forecasts

August 2024 | | ID: 2AF18D5253F1EN
Venture Planning Group

Abstracts

This new 340-page report from LeadingMarketResearch.com contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market. RationaleThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.Market Segmentation Analysis%li%Review of three POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.%li%Five-year test volume and reagent sales forecasts for lipid tests by market segment:%li%Physician Offices/Group Practices %li%Emergency Rooms %li%Ambulatory Care Centers Competitive Assessments%li%Assessments of major POC suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.Strategic Recommendations%li%Specific opportunities for new instruments and reagent systems with potentially significant market appeal during the next five years.%li%Design criteria for POC testing products.%li%Alternative business expansion strategies.%li%Potential market entry barriers and risks.MethodologyThis report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.Contains 340 pages and 36 tables

Contents

Introduction
Executive Summary
Rationale for Testing Decentralization

1. OVERVIEW

2. REGULATORY TRENDS

3. ECONOMIC TRENDS

4. DEMOGRAPHIC TRENDS

5. TECHNOLOGICAL TRENDS

6. SOCIAL TRENDS

7. QUALITY OF CARE

8. DEFENSIVE MEDICINE

9. QUALITY CONTROL ISSUES

Lipid Test: Significance and Diagnostic Procedures

1. CHOLESTEROL

2. HIGH-DENSITY LIPOPROTEIN (HDL)

3. LOW-DENSITY LIPOPROTEIN (LDL)

4. TRIGLYCERIDES

POC Testing Instrumentation
- Abaxis
- Abbott
- Alfa Wassermann
- Awareness Technologies
- Beckman Coulter/Danaher
- bioMeriuex
- Carolina Chemistries
- Horiba
- Inverness
- Medica
- Nova Biomedical
- Ortho-Clinical Diagnostics
- Polimedco
- Randox
- Roche
Table of Contents (continued)
Current and Emerging Technologies

1. MONOCLONAL ANTIBODIES

2. IMMUNOASSAYS

a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation

3. DRY CHEMISTRY

4. BIOSENSORS

5. IT AND AUTOMATION

U.S.A.
A. Market Overview

1. BUSINESS ENVIRONMENT

a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics